| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |